Home » Authors » Karen Young

Karen Young

Articles

ARTICLES

Dynavax Raises $34.8M In Series D To Continue Development Work

April 26, 2002

Replidyne Raises $13 Million In Series A For Antimicrobials

April 26, 2002

Dynavax Raises $34.8M In Series D To Continue Development Work

April 26, 2002

Allos Raises $15 Million In Private Placement With Perseus-Soros

April 25, 2002

Poor Phase IIb Data On Stroke Drug Drops Corvas’ Stock

April 25, 2002

Allos Raises $15 Million In Private Placement With Perseus-Soros

April 25, 2002

Poor Phase IIb Data On Stroke Drug Drops Corvas’ Stock

April 25, 2002

NeoPharm Attributes LEP Results To Use Of Pharmacia Formulation

April 24, 2002

NeoPharm Attributes LEP Results To Use Of Pharmacia Formulation

April 24, 2002

Array, Callisto Enter Alliance To Discover New Antibiotics

April 23, 2002

View All Articles by Karen Young

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...